New ACOG Guidance Urges Routine Fallopian Tube Removal for Ovarian Cancer Prevention
The American College of Obstetricians and Gynecologists updated its guidance to recommend opportunistic bilateral salpingectomy during hysterectomy and other surgical procedures. Evidence shows removing the fallopian tubes can reduce lifetime ovarian cancer risk by up to 78%. A Canadian study of over 80,000 patients found an almost 80% lower risk of serous ovarian cancer with the procedure.
The updated ACOG guidance, published in Obstetrics and Gynecology, marks a significant shift toward proactive prevention. Evidence cited includes a Canadian study of over 80,000 patients showing nearly 80% lower serous ovarian cancer incidence with bilateral salpingectomy during hysterectomy versus hysterectomy alone. The European Society of Gynaecological Oncology similarly endorsed the procedure after reviewing 129 published articles.
Despite strong data, awareness remains limited. A prior study found that one-quarter of 2,000 women later diagnosed with ovarian cancer had undergone earlier abdomino-pelvic or sterilization surgeries where OBS could have been performed. Among those with first-degree relatives affected, over 40% had genetic susceptibility identified only after their own cancer diagnosis, highlighting missed prevention opportunities.
This guidance could meaningfully reshape surgical practice, potentially reducing ovarian cancer incidence among women undergoing